Literature DB >> 2298909

Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

S T Pottratz1, W J Martin.   

Abstract

Attachment of pathogens to host cells is a prerequisite for the development of many infections. Pneumocystis carinii (PC) pneumonia is characterized by attachment of PC trophozoites to the alveolar epithelium. The mechanism of this process is unknown. Fibronectin (Fn) is a glycoprotein present in the alveolar space known to mediate cell-cell attachment, including the attachment of certain pathogens to host epithelial cells. In this study the binding of Fn to PC trophozoites has been characterized in vitro using 125I-Fn. Fn binds saturably and specifically to 6.4 x 10(5) binding sites per organism with an apparent binding constant, Kd, of 1.2 x 10(-8) M. Fn binding to PC was inhibited by the addition of Arg-Gly-Asp-Ser (RGDS), a tetrapeptide containing the active site of the cell-binding domain of Fn. PC attachment to an alveolar epithelial cell line was quantified using 51Cr-labeled PC trophozoites. Attachment was decreased from 24 +/- 1.9% to 12.1 +/- 1% (P less than 0.01) by the addition of an anti-Fn antibody, an effect that could be overcome by the addition of excess free Fn. It is concluded that binding of Fn to PC may be an important initial step in the attachment of the organism to alveolar epithelial cells. Furthermore, it appears that PC recognizes and binds to the RGDS cell attachment site of Fn.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298909      PMCID: PMC296431          DOI: 10.1172/JCI114445

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin.

Authors:  S K Akiyama; K M Yamada
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

2.  Amino acid sequence specificities of an adhesive recognition signal.

Authors:  K M Yamada; D W Kennedy
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

3.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

4.  In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment.

Authors:  D J Wyler; J P Sypek; J A McDonald
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.

Authors:  E F Plow; M D Pierschbacher; E Ruoslahti; G A Marguerie; M H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Binding sites for streptococci and staphylococci in fibronectin.

Authors:  P Kuusela; T Vartio; M Vuento; E B Myhre
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin.

Authors:  R Pytela; M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.

Authors:  T K Gartner; J S Bennett
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  Detachment of cells from culture substrate by soluble fibronectin peptides.

Authors:  E G Hayman; M D Pierschbacher; E Ruoslahti
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

10.  Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain.

Authors:  D D Thomas; J B Baseman; J F Alderete
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 3.  Host cell invasion by medically important fungi.

Authors:  Donald C Sheppard; Scott G Filler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  The Pneumocystis Ace2 transcription factor regulates cell wall-remodeling genes and organism virulence.

Authors:  Theodore J Kottom; Andrew H Limper
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

5.  Pneumocystis carinii attachment increases expression of fibronectin-binding integrins on cultured lung cells.

Authors:  S T Pottratz; A L Weir; P E Wisniowski
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Isolation and characterization of a recombinant antigen of Pneumocystis carinii.

Authors:  A G Smulian; J R Stringer; M J Linke; P D Walzer
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells.

Authors:  A H Limper; J E Standing; O A Hoffman; M Castro; L W Neese
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.

Authors:  C Atzori; A Bruno; G Chichino; E Bombardelli; M Scaglia; M Ghione
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

10.  Characterization of a novel ADAM protease expressed by Pneumocystis carinii.

Authors:  Cassie C Kennedy; Theodore J Kottom; Andrew H Limper
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.